Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8626
Westlake Chemical Partners
WLKP
$763M
| $477K | ﹤0.01% |
20,614
-15,297
| -43% | -$351K |
|
|
NSLR
8627
Neostellar Capital Corp
NSLR
$268M
| $476K | ﹤0.01% |
+81,008
| New | +$414K |
|
|
JNPR
8628
CALL
DELISTED
Juniper Networks
JNPR
| $476K | ﹤0.01% |
12,700
-17,400
| -58% | -$658K |
|
8629
Roundhill Ball Metaverse ETF
METV
$210M
| $476K | ﹤0.01% |
33,068
+16,170
| +96% | +$228K |
|
8630
CALL
iShares US Financials ETF
IYF
$4.4B
| $475K | ﹤0.01% |
4,300
-5,400
| -56% | -$601K |
|
|
HSAI
8631
CALL
Hesai Group
HSAI
$2.67B
| $475K | ﹤0.01% |
34,400
+10,300
| +43% | +$72.5K |
|
8632
PUT
Archrock
AROC
$6.01B
| $475K | ﹤0.01% |
19,100
+5,100
| +36% | +$118K |
|
|
OCTM
8633
FT Vest U.S. Equity Max Buffer ETF - October
OCTM
$31.4M
| $475K | ﹤0.01% |
+15,577
| New | +$475K |
|
8634
PUT
Mitek Systems
MITK
$833M
| $475K | ﹤0.01% |
42,700
+7,500
| +21% | +$70K |
|
8635
CALL
Gentherm
THRM
$1.29B
| $475K | ﹤0.01% |
11,900
-6,300
| -35% | -$264K |
|
8636
Alto Ingredients
ALTO
$329M
| $475K | ﹤0.01% |
304,521
+187,019
| +159% | +$293K |
|
8637
CALL
Methanex
MEOH
$4.44B
| $474K | ﹤0.01% |
9,500
+700
| +8% | +$30.8K |
|
8638
PUT
Leggett & Platt
LEG
$1.3B
| $474K | ﹤0.01% |
49,400
-27,600
| -36% | -$330K |
|
8639
PUT
Universal Insurance Holdings
UVE
$1.19B
| $474K | ﹤0.01% |
22,500
+21,700
| +2,713% | +$454K |
|
8640
Crescent Capital BDC
CCAP
$400M
| $474K | ﹤0.01% |
24,653
-23,227
| -49% | -$439K |
|
8641
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.64B
| $474K | ﹤0.01% |
16,669
-2,933
| -15% | -$86.9K |
|
|
ATSG
8642
CALL
DELISTED
Air Transport Services Group
ATSG
| $473K | ﹤0.01% |
21,500
-31,600
| -60% | -$625K |
|
|
CTV
8643
DELISTED
Innovid Corp.
CTV
| $472K | ﹤0.01% |
152,819
+72,531
| +90% | +$171K |
|
8644
CALL
CAE Inc
CAE
$8.4B
| $472K | ﹤0.01% |
18,600
-14,000
| -43% | -$295K |
|
|
LOMA
8645
CALL
Loma Negra
LOMA
$1.07B
| $472K | ﹤0.01% |
39,500
+24,800
| +169% | +$257K |
|
8646
PUT
Amylyx Pharmaceuticals
AMLX
$3.73B
| $471K | ﹤0.01% |
124,600
-36,100
| -22% | -$170K |
|
8647
Invesco S&P MidCap Momentum ETF
XMMO
$7.51B
| $471K | ﹤0.01% |
3,809
-2,622
| -41% | -$333K |
|
|
BZUN
8648
Baozun
BZUN
$159M
| $470K | ﹤0.01% |
172,961
+99,821
| +136% | +$302K |
|
8649
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.2B
| $470K | ﹤0.01% |
4,687
-310,050
| -99% | -$31.2M |
|
|
HPP
8650
CALL
Hudson Pacific Properties
HPP
$744M
| $470K | ﹤0.01% |
22,171
+18,700
| +539% | +$511K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.